TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
CombiGene AB
Closing information (x1000 DKK)
Closing information | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Turnover |
3,724
|
17,841
|
61,110 |
Financial expenses |
3
|
1
|
0 |
Earnings before taxes |
-23,955
|
-4,114
|
15,244 |
EBITDA |
-24,164
|
-2,908
|
17,131 |
Total assets |
81,012
|
105,729
|
120,865 |
Current assets |
69,343
|
93,029
|
105,159 |
Current liabilities |
2,791
|
4,076
|
5,775 |
Equity capital |
78,221
|
101,653
|
115,090 |
- share capital |
665
|
662
|
720 |
Employees (average) |
8
|
10
|
8 |
Financial ratios
Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Solvency |
96.6%
|
96.1%
|
95.2% |
Turnover per employee |
466
|
1,784
|
7,639 |
Profit as a percentage of turnover |
-643.3%
|
-23.1%
|
24.9% |
Return on assets (ROA) |
-29.6%
|
-3.9%
|
12.6% |
Current ratio |
2484.5%
|
2282.4%
|
1820.9% |
Return on equity (ROE) |
-30.6%
|
-4.0%
|
13.2% |
Change turnover |
-14,209
|
-38,318
|
61,110 |
Change turnover % |
-79%
|
-68% | |
Chg. No. of employees |
-2
|
2
|
4 |
Chg. No. of employees % |
-20%
|
25%
|
100% |
Total value of public sale
Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.